IF by specialty › Urology & Nephrology
Urologic Oncology: Seminars and Original Investigations — Impact Factor
The 2025 Impact Factor of Urologic Oncology: Seminars and Original Investigations is 2.8 (quartile not confirmed; subscription or hybrid).
- Impact Factor
- 2.8 JCR 2025
- JCR category
- Urology & Nephrology
- Quartile
- quartile not confirmed
- Publisher
- Elsevier (Society of Urologic Oncology)
- Open access
- subscription or hybrid
- IF source
- sciencedirect.com
Position within the field
Ranked 28 of the 41 journals in Urology & Nephrology on this site (bottom 50%).
Urology & Nephrology journals with a similar Impact Factor
- International Journal of Urology IF 2.9
- Asian Journal of Urology IF 2.7
- The Prostate IF 2.7
- Journal of Nephrology IF 2.6
- Urolithiasis IF 2.6
- Pediatric Nephrology IF 2.5
About this value
The Journal Impact Factor of Urologic Oncology: Seminars and Original Investigations (JCR 2025, released June 2026) is 2.8. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Urology & Nephrology.